These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32002295)

  • 1. The M2 macrophage marker
    Xu ZJ; Gu Y; Wang CZ; Jin Y; Wen XM; Ma JC; Tang LJ; Mao ZW; Qian J; Lin J
    Oncoimmunology; 2020; 9(1):1683347. PubMed ID: 32002295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression of BAALC, CDKN1B, ERG, and MN1 adds independent prognostic information to cytogenetics and molecular mutations in adult acute myeloid leukemia.
    Haferlach C; Kern W; Schindela S; Kohlmann A; Alpermann T; Schnittger S; Haferlach T
    Genes Chromosomes Cancer; 2012 Mar; 51(3):257-65. PubMed ID: 22072540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
    Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Ke X; Fu L
    Ann Hematol; 2018 Aug; 97(8):1391-1397. PubMed ID: 29696374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers.
    Rockova V; Abbas S; Wouters BJ; Erpelinck CA; Beverloo HB; Delwel R; van Putten WL; Löwenberg B; Valk PJ
    Blood; 2011 Jul; 118(4):1069-76. PubMed ID: 21596848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays.
    Metzeler KH; Dufour A; Benthaus T; Hummel M; Sauerland MC; Heinecke A; Berdel WE; Büchner T; Wörmann B; Mansmann U; Braess J; Spiekermann K; Hiddemann W; Buske C; Bohlander SK
    J Clin Oncol; 2009 Oct; 27(30):5031-8. PubMed ID: 19752345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIGIT blockade repolarizes AML-associated TIGIT
    Brauneck F; Fischer B; Witt M; Muschhammer J; Oelrich J; da Costa Avelar PH; Tsoka S; Bullinger L; Seubert E; Smit DJ; Bokemeyer C; Ackermann C; Wellbrock J; Haag F; Fiedler W
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36549780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia.
    Staffas A; Kanduri M; Hovland R; Rosenquist R; Ommen HB; Abrahamsson J; Forestier E; Jahnukainen K; Jónsson ÓG; Zeller B; Palle J; Lönnerholm G; Hasle H; Palmqvist L; Ehrencrona H;
    Blood; 2011 Nov; 118(22):5905-13. PubMed ID: 21967978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia.
    Hasan SK; Patkar NV; Rajamanickam D; Gokarn A; Lucena-Araujo AR; Tembhare P; Bagal B; Kadam Amare P; Jain H; Gujral S; Sengar M; Subramanian PG; Khattry N
    Hematol Oncol; 2020 Dec; 38(5):808-816. PubMed ID: 32893896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of combined BAALC and MN1 gene expression level in acute myeloid leukemia with normal karyotype.
    Marjanovic I; Karan-Djurasevic T; Kostic T; Virijevic M; Vukovic NS; Pavlovic S; Tosic N
    Int J Lab Hematol; 2021 Jun; 43(3):433-440. PubMed ID: 33242229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.
    Baldus CD; Tanner SM; Ruppert AS; Whitman SP; Archer KJ; Marcucci G; Caligiuri MA; Carroll AJ; Vardiman JW; Powell BL; Allen SL; Moore JO; Larson RA; Kolitz JE; de la Chapelle A; Bloomfield CD
    Blood; 2003 Sep; 102(5):1613-8. PubMed ID: 12750167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis.
    Wu X; Wang H; Deng J; Zheng X; Ling Y; Gong Y
    Ann Hematol; 2019 Nov; 98(11):2485-2496. PubMed ID: 31482295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).
    Santamaría C; Chillón MC; García-Sanz R; Pérez C; Caballero MD; Mateos MV; Ramos F; de Coca AG; Alonso JM; Giraldo P; Bernal T; Queizán JA; Rodríguez JN; Puig N; Balanzategui A; Sarasquete ME; Alcoceba M; Díaz-Mediavilla J; San Miguel J; González M
    Ann Hematol; 2010 May; 89(5):453-8. PubMed ID: 19943049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL3 Expression Is a Potential Prognostic and Predictive Biomarker in Acute Myeloid Leukemia of FAB Subtype M2.
    Niu Y; Yang X; Chen Y; Zhang L; Jin X; Tang Y; Li L; Yu L; Guo Y; Wang H
    Pathol Oncol Res; 2019 Apr; 25(2):541-548. PubMed ID: 30357752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes.
    Thol F; Yun H; Sonntag AK; Damm F; Weissinger EM; Krauter J; Wagner K; Morgan M; Wichmann M; Göhring G; Bug G; Ottmann O; Hofmann WK; Schambach A; Schlegelberger B; Haferlach T; Bowen D; Mills K; Ganser A; Heuser M
    Ann Hematol; 2012 Aug; 91(8):1221-33. PubMed ID: 22488406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative prognostic risk score in acute myeloid leukemia with normal karyotype.
    Damm F; Heuser M; Morgan M; Wagner K; Görlich K; Grosshennig A; Hamwi I; Thol F; Surdziel E; Fiedler W; Lübbert M; Kanz L; Reuter C; Heil G; Delwel R; Löwenberg B; Valk PJ; Krauter J; Ganser A
    Blood; 2011 Apr; 117(17):4561-8. PubMed ID: 21372155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis: A biomarker of high-risk phenotype in pediatric acute myeloid leukemia?
    Tyagi A; Pramanik R; Bakhshi R; Vishnubhatla S; Bakhshi S
    Int J Lab Hematol; 2019 Feb; 41(1):141-147. PubMed ID: 30383325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
    Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
    J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.
    Heuser M; Beutel G; Krauter J; Döhner K; von Neuhoff N; Schlegelberger B; Ganser A
    Blood; 2006 Dec; 108(12):3898-905. PubMed ID: 16912223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.